QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
about
Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approachesAdvances in quantitative structure-activity relationship models of anti-Alzheimer's agents.Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.Alzheimer: A decade of drug design. Why molecular topology can be an extra edge.
P2860
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@en
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@nl
type
label
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@en
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@nl
prefLabel
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@en
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@nl
P2093
P2860
P1433
P1476
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.
@en
P2093
Kamalakaran Anand Solomon
Srinivasan Sundararajan
Veluchamy Abirami
P2860
P304
P356
10.3390/MOLECULES14041448
P407
P577
2009-04-07T00:00:00Z